VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $8,000 | +14.3% | 1,250 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $7,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $7,000 | -22.2% | 1,250 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $9,000 | +50.0% | 1,250 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $6,000 | -40.0% | 1,250 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $10,000 | +11.1% | 1,250 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $9,000 | -10.0% | 1,250 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $10,000 | -16.7% | 1,250 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $12,000 | +20.0% | 1,250 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $10,000 | -54.5% | 1,250 | 0.0% | 0.00% | -66.7% |
Q3 2018 | $22,000 | +83.3% | 1,250 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $12,000 | +140.0% | 1,250 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $5,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,000 | +150.0% | 1,250 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 1,250 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 1,250 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 1,250 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | – | 1,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |